Hetero launches TAFFIC, the latest 3-in-1 single pill for HIV treatment. - Express Pharma
Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens | Infectious Diseases and Therapy
Dolutegravir/Lamivudine Single-Tablet Regimen: A Review in HIV-1 Infection | springermedizin.de
FDA Approves Gilead's Single-Tablet HIV Regimen Biktarvy - POZ